Cardarone is a prescription medication classified as an antiarrhythmic agent. Its primary therapeutic purpose is to maintain normal heart rhythm in patients with various types of irregular heartbeat. The drug acts by stabilizing cardiac cell membranes and prolonging the duration of the action potential. It blocks several ion channels including potassium sodium and calcium currents that modulate electrical activity. By inhibiting potassium efflux it reduces the resting membrane potential and slows the repolarization phase. Inhibition of sodium channels prolongs the plateau phase of the cardiac action potential. Calcium channel blockade further contributes to the lengthening of the refractory period. These combined effects decrease the likelihood of abnormal electrical circuits that cause arrhythmias.

Cardarone is an antiarrhythmic medication used to treat certain heart rhythm disorders. It works by blocking several cardiac ion channels including potassium sodium and calcium to prolong the refractory period of heart muscle cells. The drug also has beta-adrenergic blocking activity that further stabilizes electrical activity. These combined effects reduce abnormal electrical impulses that can cause tachyarrhythmia. Pharmacodynamically Cardarone produces dose-dependent changes in the qt interval prolongation and effective refractory time. The pharmacological profile is characterized by a slow onset but prolonged duration of action due to the lipophilic accumulation in cardiac tissue.

Cardarone may cause skin reactions such as rash or photosensitivity in some individuals. Gastrointestinal disturbances like nausea or loss of appetite are occasionally reported. Patients may experience mild liver enzyme elevations without obvious symptoms. Changes in thyroid function including both overactivity and underactivity have been observed. Some users develop persistent cough or shortness of breath unrelated to heart conditions. Taste disturbances such as a metallic or bitter flavor can appear during treatment.

Common side effects of Cardarone may include dizziness or lightheadedness. Patients sometimes report fatigue or unusual tiredness. Nausea or mild stomach discomfort can occur. Constipation or changes in bowel habits are possible. Tingling or shaking of the hands and feet may be noticed. Some people experience visual disturbances such as blurred vision. Irregular heartbeat or slow pulse rates can develop. Skin reactions like rash or itching may appear.